Tetrathiomolybdate is an oral, small-molecule, anticopper agent that is highly specific for lowering the levels of free copper in serum. COPREXA has completed pivotal clinical trials for the treatment of neurologic Wilson's disease. It is also developed for fibrotic disorders based upon the rationale that the fibrotic disease process is dependent upon the av...
Investigated for use/treatment in liver disease and pulmonary fibrosis.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.